3 Stocks Under $50 We’re Skeptical Of
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced changes to its Board of Directors. At the...
Bausch + Lomb (NYSE:BLCO) Exceeds Q2 CY2026 Expectations
Revenue of $1.394 Billion Revenue Grew 9% as Reported and 8% on a Constant Currency 1 Basis Compared to the Second Quarter...
Barchart Research What to Expect from BLCO Earnings BLCO Generated July 28, 2026 Current Price $16.61 EPS Estimate $$0.16 Consensus Rating Hold Average Move 3.83% Bausch & Lomb's Revenue Momentum Meets...
Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect
3 Reasons to Avoid BLCO and 1 Stock to Buy Instead
EyeGility is designed for the enVista® family of IOLs Offers balanced push force for smooth delivery, convenient one-handed operation ...
Why Bausch + Lomb (BLCO) Stock Is Trading Lower Today